Dr. Przemyslaw Leszek, Molecular characterization of human heart failure samples, Institute of Cardiology, Warszawa, Poland
Prof. Rainer Schulz, Dr. Kerstin Boengler, Cardiac mitochondrial dysfunction and oxidative stress in metabolic syndrome, Department of Physiology, Justus-Liebig University, Giessen, Germany
Dr. Luca Mendler, Role of myostatin and IGF axis in heart failure, Department of Biochemistry, Goethe University, Frankfurt am Main, Germany
Prof. Zsuzsanna Helyes, Characterization of cardiac dysfunction in a mouse model of chronic cigarette smoke exposure, Department of Pharmacology, University of Pécs, Pécs, Hungary
Prof. Mariann Gyongyosi, Department of Cardiology, Medical University of Vienna, Vienna, Austria
Dr. Pal Pacher, Dr. George Kunos., Former postdoctoral mentors. Collaborations on studying the endocannabinoid system in various cardiovascular disease states. Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD., USA
Dr. Thomas H. Schindler, Associate professor of radiology at Washington University School of Medicine, St. Louis, MO, USA
Dr. Mario van der Stelt, Laboratory of Molecular Physiology, Leiden Institute of Chemistry, University of Leiden, Leiden, The Netherlands
Dr. Tony Jourdan, Equipe Physiopathologie des Dyslipidémies (PADYS), Université de Bourgogne Franche, Dijon, France.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.